nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—PIK3CB—CXCR3-mediated signaling events—CXCL11—nasal cavity cancer	0.0384	0.0384	CbGpPWpGaD
Caffeine—PIK3CA—CXCR3-mediated signaling events—CXCL11—nasal cavity cancer	0.0303	0.0303	CbGpPWpGaD
Caffeine—PIK3CD—Toll-like Receptor Signaling Pathway—CXCL11—nasal cavity cancer	0.02	0.02	CbGpPWpGaD
Caffeine—PIK3CA—Signaling events regulated by Ret tyrosine kinase—FRS2—nasal cavity cancer	0.0175	0.0175	CbGpPWpGaD
Caffeine—PIK3CB—Toll-like Receptor Signaling Pathway—CXCL11—nasal cavity cancer	0.0174	0.0174	CbGpPWpGaD
Caffeine—PIK3CD—Regulation of toll-like receptor signaling pathway—CXCL11—nasal cavity cancer	0.0156	0.0156	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by FGFR mutants—FRS2—nasal cavity cancer	0.0156	0.0156	CbGpPWpGaD
Caffeine—PIK3CB—PI3K Cascade—FRS2—nasal cavity cancer	0.0142	0.0142	CbGpPWpGaD
Caffeine—PIK3CA—Toll-like Receptor Signaling Pathway—CXCL11—nasal cavity cancer	0.0137	0.0137	CbGpPWpGaD
Caffeine—PIK3CB—Regulation of toll-like receptor signaling pathway—CXCL11—nasal cavity cancer	0.0136	0.0136	CbGpPWpGaD
Caffeine—PIK3CD—Constitutive PI3K/AKT Signaling in Cancer—FRS2—nasal cavity cancer	0.0135	0.0135	CbGpPWpGaD
Caffeine—PIK3CA—FGF signaling pathway—FRS2—nasal cavity cancer	0.0135	0.0135	CbGpPWpGaD
Caffeine—PIK3CA—SHP2 signaling—FRS2—nasal cavity cancer	0.0127	0.0127	CbGpPWpGaD
Caffeine—PIK3CA—Neurotrophic factor-mediated Trk receptor signaling—FRS2—nasal cavity cancer	0.0122	0.0122	CbGpPWpGaD
Caffeine—PIK3CD—PI-3K cascade—FRS2—nasal cavity cancer	0.0122	0.0122	CbGpPWpGaD
Caffeine—PIK3CB—IRS-mediated signalling—FRS2—nasal cavity cancer	0.0119	0.0119	CbGpPWpGaD
Caffeine—PIK3CD—PI3K/AKT activation—FRS2—nasal cavity cancer	0.0119	0.0119	CbGpPWpGaD
Caffeine—PIK3CD—GAB1 signalosome—FRS2—nasal cavity cancer	0.0118	0.0118	CbGpPWpGaD
Caffeine—PIK3CB—Constitutive PI3K/AKT Signaling in Cancer—FRS2—nasal cavity cancer	0.0118	0.0118	CbGpPWpGaD
Caffeine—PIK3CB—IRS-related events—FRS2—nasal cavity cancer	0.0116	0.0116	CbGpPWpGaD
Caffeine—PIK3CD—Role of LAT2/NTAL/LAB on calcium mobilization—FRS2—nasal cavity cancer	0.0115	0.0115	CbGpPWpGaD
Caffeine—PIK3CB—IRS-related events triggered by IGF1R—FRS2—nasal cavity cancer	0.0115	0.0115	CbGpPWpGaD
Caffeine—PIK3CA—PI3K Cascade—FRS2—nasal cavity cancer	0.0112	0.0112	CbGpPWpGaD
Caffeine—PIK3CB—IGF1R signaling cascade—FRS2—nasal cavity cancer	0.0112	0.0112	CbGpPWpGaD
Caffeine—PIK3CB—Insulin receptor signalling cascade—FRS2—nasal cavity cancer	0.0112	0.0112	CbGpPWpGaD
Caffeine—PIK3CA—Regulation of toll-like receptor signaling pathway—CXCL11—nasal cavity cancer	0.0107	0.0107	CbGpPWpGaD
Caffeine—PIK3CB—PI-3K cascade—FRS2—nasal cavity cancer	0.0106	0.0106	CbGpPWpGaD
Caffeine—PIK3CB—PI3K/AKT activation—FRS2—nasal cavity cancer	0.0104	0.0104	CbGpPWpGaD
Caffeine—PIK3CB—GAB1 signalosome—FRS2—nasal cavity cancer	0.0103	0.0103	CbGpPWpGaD
Caffeine—PIK3CB—Role of LAT2/NTAL/LAB on calcium mobilization—FRS2—nasal cavity cancer	0.01	0.01	CbGpPWpGaD
Caffeine—PIK3CA—IRS-mediated signalling—FRS2—nasal cavity cancer	0.00937	0.00937	CbGpPWpGaD
Caffeine—PIK3CA—Constitutive PI3K/AKT Signaling in Cancer—FRS2—nasal cavity cancer	0.00929	0.00929	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by Insulin receptor—FRS2—nasal cavity cancer	0.00928	0.00928	CbGpPWpGaD
Caffeine—PIK3CA—IRS-related events—FRS2—nasal cavity cancer	0.00912	0.00912	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by SCF-KIT—FRS2—nasal cavity cancer	0.0091	0.0091	CbGpPWpGaD
Caffeine—PIK3CA—IRS-related events triggered by IGF1R—FRS2—nasal cavity cancer	0.00904	0.00904	CbGpPWpGaD
Caffeine—PIK3CA—IGF1R signaling cascade—FRS2—nasal cavity cancer	0.0088	0.0088	CbGpPWpGaD
Caffeine—PIK3CA—Insulin receptor signalling cascade—FRS2—nasal cavity cancer	0.0088	0.0088	CbGpPWpGaD
Caffeine—PIK3CD—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.00871	0.00871	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by ERBB4—FRS2—nasal cavity cancer	0.00857	0.00857	CbGpPWpGaD
Caffeine—PIK3CA—PI-3K cascade—FRS2—nasal cavity cancer	0.00837	0.00837	CbGpPWpGaD
Caffeine—PIK3CD—Downstream signal transduction—FRS2—nasal cavity cancer	0.00819	0.00819	CbGpPWpGaD
Caffeine—PIK3CA—PI3K/AKT activation—FRS2—nasal cavity cancer	0.00817	0.00817	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by FGFR—FRS2—nasal cavity cancer	0.00815	0.00815	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by ERBB2—FRS2—nasal cavity cancer	0.00811	0.00811	CbGpPWpGaD
Caffeine—PIK3CA—GAB1 signalosome—FRS2—nasal cavity cancer	0.0081	0.0081	CbGpPWpGaD
Caffeine—PIK3CD—DAP12 signaling—FRS2—nasal cavity cancer	0.00807	0.00807	CbGpPWpGaD
Caffeine—PIK3CD—Downstream signaling events of B Cell Receptor (BCR)—FRS2—nasal cavity cancer	0.00795	0.00795	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by SCF-KIT—FRS2—nasal cavity cancer	0.00793	0.00793	CbGpPWpGaD
Caffeine—PIK3CA—Role of LAT2/NTAL/LAB on calcium mobilization—FRS2—nasal cavity cancer	0.00792	0.00792	CbGpPWpGaD
Caffeine—PIK3CB—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.00759	0.00759	CbGpPWpGaD
Caffeine—PIK3CD—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.00759	0.00759	CbGpPWpGaD
Caffeine—PIK3CD—DAP12 interactions—FRS2—nasal cavity cancer	0.00759	0.00759	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.00759	0.00759	CbGpPWpGaD
Caffeine—ADORA1—G alpha (i) signalling events—CXCL11—nasal cavity cancer	0.00754	0.00754	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by EGFR—FRS2—nasal cavity cancer	0.00752	0.00752	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by ERBB4—FRS2—nasal cavity cancer	0.00747	0.00747	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.00745	0.00745	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by PDGF—FRS2—nasal cavity cancer	0.00742	0.00742	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by Insulin receptor—FRS2—nasal cavity cancer	0.00731	0.00731	CbGpPWpGaD
Caffeine—PIK3CB—Downstream signal transduction—FRS2—nasal cavity cancer	0.00714	0.00714	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by FGFR—FRS2—nasal cavity cancer	0.0071	0.0071	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by ERBB2—FRS2—nasal cavity cancer	0.00707	0.00707	CbGpPWpGaD
Caffeine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.00705	0.00705	CbGpPWpGaD
Caffeine—PIK3CB—DAP12 signaling—FRS2—nasal cavity cancer	0.00703	0.00703	CbGpPWpGaD
Caffeine—PIK3CD—B Cell Activation—FRS2—nasal cavity cancer	0.00702	0.00702	CbGpPWpGaD
Caffeine—PIK3CB—Downstream signaling events of B Cell Receptor (BCR)—FRS2—nasal cavity cancer	0.00693	0.00693	CbGpPWpGaD
Caffeine—PIK3CD—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.00672	0.00672	CbGpPWpGaD
Caffeine—PIK3CB—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.00662	0.00662	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.00662	0.00662	CbGpPWpGaD
Caffeine—PIK3CB—DAP12 interactions—FRS2—nasal cavity cancer	0.00662	0.00662	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by EGFR—FRS2—nasal cavity cancer	0.00656	0.00656	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.0065	0.0065	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by PDGF—FRS2—nasal cavity cancer	0.00647	0.00647	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by SCF-KIT—FRS2—nasal cavity cancer	0.00625	0.00625	CbGpPWpGaD
Caffeine—PIK3CB—B Cell Activation—FRS2—nasal cavity cancer	0.00612	0.00612	CbGpPWpGaD
Caffeine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.00599	0.00599	CbGpPWpGaD
Caffeine—PIK3CA—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.00598	0.00598	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by ERBB4—FRS2—nasal cavity cancer	0.00589	0.00589	CbGpPWpGaD
Caffeine—PIK3CB—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.00586	0.00586	CbGpPWpGaD
Caffeine—PIK3CA—Downstream signal transduction—FRS2—nasal cavity cancer	0.00562	0.00562	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by FGFR—FRS2—nasal cavity cancer	0.0056	0.0056	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by ERBB2—FRS2—nasal cavity cancer	0.00557	0.00557	CbGpPWpGaD
Caffeine—PIK3CA—DAP12 signaling—FRS2—nasal cavity cancer	0.00554	0.00554	CbGpPWpGaD
Caffeine—PIK3CA—Downstream signaling events of B Cell Receptor (BCR)—FRS2—nasal cavity cancer	0.00546	0.00546	CbGpPWpGaD
Caffeine—ADORA2B—GPCR ligand binding—CXCL11—nasal cavity cancer	0.00537	0.00537	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.00521	0.00521	CbGpPWpGaD
Caffeine—PIK3CA—DAP12 interactions—FRS2—nasal cavity cancer	0.00521	0.00521	CbGpPWpGaD
Caffeine—PIK3CA—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.00521	0.00521	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by NGF—FRS2—nasal cavity cancer	0.00517	0.00517	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by EGFR—FRS2—nasal cavity cancer	0.00517	0.00517	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.00512	0.00512	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by PDGF—FRS2—nasal cavity cancer	0.0051	0.0051	CbGpPWpGaD
Caffeine—ABCB1—Allograft Rejection—CXCL11—nasal cavity cancer	0.00484	0.00484	CbGpPWpGaD
Caffeine—PIK3CA—B Cell Activation—FRS2—nasal cavity cancer	0.00482	0.00482	CbGpPWpGaD
Caffeine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.00463	0.00463	CbGpPWpGaD
Caffeine—PIK3CA—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.00462	0.00462	CbGpPWpGaD
Caffeine—PRKDC—Innate Immune System—FRS2—nasal cavity cancer	0.00461	0.00461	CbGpPWpGaD
Caffeine—ADORA1—GPCR ligand binding—CXCL11—nasal cavity cancer	0.00456	0.00456	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by NGF—FRS2—nasal cavity cancer	0.00451	0.00451	CbGpPWpGaD
Caffeine—ADORA2A—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.00381	0.00381	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by NGF—FRS2—nasal cavity cancer	0.00355	0.00355	CbGpPWpGaD
Caffeine—ADORA2A—GPCR ligand binding—CXCL11—nasal cavity cancer	0.00352	0.00352	CbGpPWpGaD
Caffeine—PIK3CD—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00351	0.00351	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00319	0.00319	CbGpPWpGaD
Caffeine—PIK3CB—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00306	0.00306	CbGpPWpGaD
Caffeine—ADORA2B—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00303	0.00303	CbGpPWpGaD
Caffeine—PIK3CD—Innate Immune System—FRS2—nasal cavity cancer	0.00295	0.00295	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by NGF—FRS2—nasal cavity cancer	0.00293	0.00293	CbGpPWpGaD
Caffeine—PIK3CD—Adaptive Immune System—FRS2—nasal cavity cancer	0.00283	0.00283	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00278	0.00278	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00275	0.00275	CbGpPWpGaD
Caffeine—PRKDC—Immune System—FRS2—nasal cavity cancer	0.00268	0.00268	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00258	0.00258	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—FRS2—nasal cavity cancer	0.00257	0.00257	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00255	0.00255	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—FRS2—nasal cavity cancer	0.00247	0.00247	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00241	0.00241	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00234	0.00234	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00231	0.00231	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00219	0.00219	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—FRS2—nasal cavity cancer	0.00203	0.00203	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00199	0.00199	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—FRS2—nasal cavity cancer	0.00194	0.00194	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—CXCL11—nasal cavity cancer	0.00188	0.00188	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00181	0.00181	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—FRS2—nasal cavity cancer	0.00172	0.00172	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CXCL11—nasal cavity cancer	0.00164	0.00164	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CXCL11—nasal cavity cancer	0.00163	0.00163	CbGpPWpGaD
Caffeine—PIK3CD—Disease—FRS2—nasal cavity cancer	0.00159	0.00159	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—FRS2—nasal cavity cancer	0.0015	0.0015	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CXCL11—nasal cavity cancer	0.00138	0.00138	CbGpPWpGaD
Caffeine—PIK3CB—Disease—FRS2—nasal cavity cancer	0.00138	0.00138	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CXCL11—nasal cavity cancer	0.00137	0.00137	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CXCL11—nasal cavity cancer	0.00129	0.00129	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—FRS2—nasal cavity cancer	0.00118	0.00118	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—FRS2—nasal cavity cancer	0.00111	0.00111	CbGpPWpGaD
Caffeine—PIK3CA—Disease—FRS2—nasal cavity cancer	0.00109	0.00109	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CXCL11—nasal cavity cancer	0.00107	0.00107	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—FRS2—nasal cavity cancer	0.000968	0.000968	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—FRS2—nasal cavity cancer	0.000959	0.000959	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—FRS2—nasal cavity cancer	0.000815	0.000815	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—FRS2—nasal cavity cancer	0.000806	0.000806	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—FRS2—nasal cavity cancer	0.000763	0.000763	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—FRS2—nasal cavity cancer	0.00063	0.00063	CbGpPWpGaD
